Roundup: The Return of Deals, the Rise of Wellness, and AI’s Coming Regulation

As startups chase hot markets like GLP-1s and testosterone, the Trump Administration continues to push on wellness - and not always with the evidence to back it up. Deals are finally ramping up (and why). Plus a “Four Questions with” interview with digital health OG Halle Tecco!

Christina Farr, +1
Sep 23, 2025
Roundup: The Return of Deals, the Rise of Wellness, and AI’s Coming Regulation

Navigating Black Swan Events in Volatile Markets

How healthcare founders should take lessons from teams navigating unpredictable events

Christina Farr, +1
Apr 7, 2025
Navigating Black Swan Events in Volatile Markets

Is it possible for employers to keep costs down and cover GLP-1s?

That’s the question of the moment - and we explore it in-depth.

Christina Farr, +1
Nov 1, 2024
Is it possible for employers to keep costs down and cover GLP-1s?